Coronary Stent Medicare Claims Review Included In HHS OIG 2004 Work Plan
This article was originally published in The Gray Sheet
Executive Summary
Inpatient and outpatient Medicare claims involving arterial stent placement will be reviewed by OIG to evaluate whether the devices are being used only when medically necessary, the agency says
You may also be interested in...
Power Wheelchairs Targeted For Inherent Reasonableness Price Adjustments
CMS plans to develop inherent reasonableness review guidelines to ensure appropriate Medicare payments for motorized wheelchairs as part of a larger initiative to curb provider billing fraud, the agency says
Drug-Eluting Stent DRGs Sustained At FY 2003 Rates – IPPS Final Rule
CMS will maintain the current DRG weights for drug-eluting stents in FY 2004, contending it is not "appropriate" to use anticipated Oct. 1 charges to set payment rates, according to the hospital 1IPPS final rule
US FDA Gene Therapy Accelerated Approval Guidance Will Describe ‘Buckets’ Of Use Scenarios
Forthcoming guidance is expected to describe areas of “low-hanging fruit” and those that are more challenging for use of the expedited pathway, Center for Biologics Evaluation and Research Director Peter Marks said.